Other Notch targets (HEY1, HEY2 and HES4) also exhibited increased transcript levels in cancer cells compared to benign prostate cells (Fig.1B), though the differences in expression were less dramatic than that observed for HES6. This evidence concerns the gene HES6 and cancer.